Astrana Health, Inc. (AMEH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Laboratory Corp. of America Holdings

Quest Diagnostics, Inc.

AMN Healthcare Services, Inc.

Teladoc Health, Inc.

Psychemedics Corp.

IQVIA Holdings, Inc.

Astrana Health, Inc.

Select Medical Holdings Corp.

National Research Corp.

Premier, Inc.

Why is Astrana Health, Inc. ?

The company has declared Negative results for the last 4 consecutive quarters

NET PROFIT(HY) At USD 16.13 MM has Grown at -51.79%
ROCE(HY) Lowest at 3.5%
RAW MATERIAL COST(Y) Grown by 21.7% (YoY)

Below par performance in long term as well as near term

Along with generating -45.24% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Astrana Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Astrana Health, Inc.

-47.26%

-0.60

68.31%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

29.47%

EBIT Growth (5y)

11.72%

EBIT to Interest (avg)

9.93

Debt to EBITDA (avg)

0.40

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

1.65

Tax Ratio

40.84%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

58.26%

ROCE (avg)

20.10%

ROE (avg)

19.00%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.90

EV to EBIT

19.76

EV to EBITDA

14.41

EV to Capital Employed

1.74

EV to Sales

0.70

PEG Ratio

Dividend Yield

ROCE (Latest)

8.80%

ROE (Latest)

5.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 130.56 MM

NET SALES(HY)

At USD 1,275.2 MM has Grown at 43.18%

-11What is not working for the Company

NET PROFIT(HY)

At USD 16.13 MM has Grown at -51.79%

ROCE(HY)

Lowest at 3.5%

RAW MATERIAL COST(Y)

Grown by 21.7% (YoY

Here's what is working for Astrana Health, Inc.

Net Sales

At USD 1,275.2 MM has Grown at 43.18%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Operating Cash Flow

Highest at USD 130.56 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Here's what is not working for Astrana Health, Inc.

Net Profit

At USD 16.13 MM has Grown at -51.79%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Raw Material Cost

Grown by 21.7% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales